Literature DB >> 21924240

Copper-mediated cross-linking of S100A4, but not of S100A2, results in proinflammatory effects in melanoma cells.

Cathleen Haase-Kohn1, Susann Wolf, Jens Lenk, Jens Pietzsch.   

Abstract

The aim of this study was to investigate the response to and the physiological consequences of copper-mediated cross-linking of S100A2 and S100A4, two members of the S100 family of EF-hand calcium-binding proteins. As demonstrated by electrophoresis and mass spectrometry techniques S100A2 and S100A4 show formation of cross-links due to copper-mediated oxidation of cysteine residues. For S100A4, but not for S100A2, this results in both increased activation of NFκB and secretion of TNF-α in human A375 and, to a higher extent, in RAGE-transfected melanoma cells. The data suggest that a prooxidative tumor microenvironment enhances proinflammatory and prometastatic action of S100A4.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21924240     DOI: 10.1016/j.bbrc.2011.08.132

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Binding of transition metals to S100 proteins.

Authors:  Benjamin A Gilston; Eric P Skaar; Walter J Chazin
Journal:  Sci China Life Sci       Date:  2016-07-19       Impact factor: 6.038

Review 2.  Ousting RAGE in melanoma: A viable therapeutic target?

Authors:  Deeba N Syed; Ahmed Aljohani; Durdana Waseem; Hasan Mukhtar
Journal:  Semin Cancer Biol       Date:  2017-10-24       Impact factor: 15.707

3.  Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.

Authors:  Nadine Herwig; Birgit Belter; Susann Wolf; Cathleen Haase-Kohn; Jens Pietzsch
Journal:  J Cell Mol Med       Date:  2016-03-01       Impact factor: 5.310

4.  Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer.

Authors:  Taiki Masuda; Toshiaki Ishikawa; Kaoru Mogushi; Satoshi Okazaki; Megumi Ishiguro; Satoru Iida; Hiroshi Mizushima; Hiroshi Tanaka; Hiroyuki Uetake; Kenichi Sugihara
Journal:  Int J Oncol       Date:  2016-01-11       Impact factor: 5.650

Review 5.  S100A4 in cancer progression and metastasis: A systematic review.

Authors:  Fei Fei; Jie Qu; Mingqing Zhang; Yuwei Li; Shiwu Zhang
Journal:  Oncotarget       Date:  2017-05-19

Review 6.  Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression.

Authors:  Ali H El-Far; Grazyna Sroga; Soad K Al Jaouni; Shaker A Mousa
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

Review 7.  Friend or Foe: S100 Proteins in Cancer.

Authors:  Chantal Allgöwer; Anna-Laura Kretz; Silvia von Karstedt; Mathias Wittau; Doris Henne-Bruns; Johannes Lemke
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

Review 8.  Influence of S100A2 in Human Diseases.

Authors:  Hitomi Sugino; Yu Sawada
Journal:  Diagnostics (Basel)       Date:  2022-07-20

9.  Orf Virus 002 Protein Targets Ovine Protein S100A4 and Inhibits NF-κB Signaling.

Authors:  Daxiang Chen; Zewei Zheng; Bin Xiao; Wei Li; Mingjian Long; Huiqin Chen; Ming Li; Daniel L Rock; Wenbo Hao; Shuhong Luo
Journal:  Front Microbiol       Date:  2016-09-13       Impact factor: 5.640

10.  Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4.

Authors:  Lina Prasmickaite; Ellen M Tenstad; Solveig Pettersen; Shakila Jabeen; Eivind V Egeland; Silje Nord; Abhilash Pandya; Mads H Haugen; Vessela N Kristensen; Anne-Lise Børresen-Dale; Olav Engebråten; Gunhild M Maelandsmo
Journal:  Mol Oncol       Date:  2018-08-09       Impact factor: 6.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.